] . Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells. J Cell Physiol 2011;226(9):2279-86.
. TRAIL promotes a pro-survival signal in erythropoietin-deprived human erythroblasts through the activation of an NF-kB/IkBalpha pathway. J Biol Regul Homeost Agents 2011;25(3):375-86.
. Two lumens, one diagnosis. J Pediatr 2011;159(3):511.
. Thoracoscopic removal of a bulky cystic mediastinal mature teratoma in a 4-year-old child: report of one case and few surgical tricks. Eur J Pediatr Surg 2012;22(4):318-20.
. TNF-related apoptosis-inducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammation. Clin Sci (Lond) 2012;123(9):547-55.
. TRAIL, a new weapon against neointimal hyperplasia. Cardiology 2012;123(2):94-6.
. TRAIL administration down-modulated the acute systemic inflammatory response induced in a mouse model by muramyldipeptide or lipopolysaccharide. Cytokine 2012;60(1):43-6.
. TRAIL as biomarker and potential therapeutic tool for cardiovascular diseases. Curr Drug Targets 2012;13(9):1215-21.
. TRAIL shows potential cardioprotective activity. Invest New Drugs 2012;30(3):1257-60.
. Treatment with pamidronate for osteoporosis complicating long-term intestinal failure. J Pediatr Gastroenterol Nutr 2012;55(5):615-8.
. Two Novel COH1 Mutations in an Italian Patient with Cohen Syndrome. Mol Syndromol 2012;3(1):30-33.
. Third trimester abdominal circumference, estimated fetal weight and uterine artery doppler for the identification of newborns small and large for gestational age. Eur J Obstet Gynecol Reprod Biol 2013;166(2):133-8.